IL264167A - Preparations and methods for the treatment of frontotemporal dementia - Google Patents

Preparations and methods for the treatment of frontotemporal dementia

Info

Publication number
IL264167A
IL264167A IL264167A IL26416719A IL264167A IL 264167 A IL264167 A IL 264167A IL 264167 A IL264167 A IL 264167A IL 26416719 A IL26416719 A IL 26416719A IL 264167 A IL264167 A IL 264167A
Authority
IL
Israel
Prior art keywords
compositions
methods
frontotemporal dementia
treating frontotemporal
treating
Prior art date
Application number
IL264167A
Other languages
English (en)
Hebrew (he)
Original Assignee
Annexon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Annexon Inc filed Critical Annexon Inc
Publication of IL264167A publication Critical patent/IL264167A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL264167A 2016-07-19 2019-01-09 Preparations and methods for the treatment of frontotemporal dementia IL264167A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662364013P 2016-07-19 2016-07-19
PCT/US2017/042846 WO2018017711A1 (fr) 2016-07-19 2017-07-19 Traitement de la démence fronto-temporale.

Publications (1)

Publication Number Publication Date
IL264167A true IL264167A (en) 2019-02-28

Family

ID=60992917

Family Applications (1)

Application Number Title Priority Date Filing Date
IL264167A IL264167A (en) 2016-07-19 2019-01-09 Preparations and methods for the treatment of frontotemporal dementia

Country Status (6)

Country Link
EP (1) EP3487531A4 (fr)
AU (1) AU2017299579A1 (fr)
CA (1) CA3030872A1 (fr)
IL (1) IL264167A (fr)
SG (1) SG11201900123TA (fr)
WO (1) WO2018017711A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015006507A1 (fr) 2013-07-09 2015-01-15 Annexon, Inc. Méthodes permettant de traiter la maladie d'alzheimer et la maladie de huntington
SG11201803703UA (en) * 2015-11-24 2018-06-28 Annexon Inc Anti-complement factor c1q fab fragments and uses thereof
CN108159421B (zh) * 2018-02-05 2021-05-18 苏州大学 磷脂酰丝氨酸阻断剂在制备治疗血小板数量减少相关疾病药物中的用途
JP7499760B2 (ja) * 2018-11-02 2024-06-14 アネクソン，インコーポレーテッド 脳損傷を治療するための組成物及び方法
IL300059A (en) 2020-07-23 2023-03-01 Othair Prothena Ltd Anti-Abata antibodies
US11958899B2 (en) 2021-07-13 2024-04-16 Mabwell Therapeutics Inc. Anti-C1s antibodies and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9480658B2 (en) * 2005-12-09 2016-11-01 The Board Of Trustees Of The Leland Stanford Junior University Modulation of synaptic maintenance
US8148330B2 (en) * 2005-12-09 2012-04-03 The Board Of Trustees Of The Leland Stanford Junior University Modulation of synaptic maintenance
AU2013334229B2 (en) * 2012-10-25 2018-02-15 Bioverativ Usa Inc. Anti-complement C1s antibodies and uses thereof
WO2015006507A1 (fr) * 2013-07-09 2015-01-15 Annexon, Inc. Méthodes permettant de traiter la maladie d'alzheimer et la maladie de huntington
EP3215527A4 (fr) * 2014-11-05 2018-04-18 Annexon, Inc. Anticorps humanisés anti-facteur du compément c1q et leurs utilisations

Also Published As

Publication number Publication date
WO2018017711A1 (fr) 2018-01-25
EP3487531A4 (fr) 2020-03-25
CA3030872A1 (fr) 2018-01-25
SG11201900123TA (en) 2019-02-27
AU2017299579A1 (en) 2019-01-24
EP3487531A1 (fr) 2019-05-29

Similar Documents

Publication Publication Date Title
IL251721A0 (en) Preparations and methods for the treatment of diseases of the central nervous system
ME03809B (fr) Compositions et méthodes pour traiter des troubles du snc
SI3224269T1 (sl) Sestavki in metode za zdravljenje CNS motenj
LT3250210T (lt) Kompozicijos ir būdai, skirti gydyti cns sutrikimus
EP3209298A4 (fr) Compositions et méthodes pour traiter l'insomnie
IL264167A (en) Preparations and methods for the treatment of frontotemporal dementia
HK1258825A1 (zh) 用於治療多汗症的方法和組合物
HK1256298A1 (zh) 用於治療和預防神經退化性病症的組合物和方法
IL291266A (en) Preparations and methods for treating infections
EP3262065C0 (fr) Procédés et compositions de traitement des dystroglycanopathies
EP3445369A4 (fr) Compositions et méthodes pour traiter la démence
EP3432913A4 (fr) Méthodes et compositions pour le traitement de l'athérosclérose
IL265255A (en) Dementia treatment preparations
EP3104896A4 (fr) Compositions et méthodes pour traiter une lésion hépatique
EP3265097A4 (fr) Compositions et méthodes de traitement et de prévention de maladies cardiovasculaires
SG11201609701UA (en) Pharmaceutical composition for preventing and treating senile dementia and preparation method thereof
EP3416668A4 (fr) Méthodes et compositions pour le traitement du mélanome
EP3270919A4 (fr) Compositions et méthodes de traitement du carcinome hépatocellulaire
GB201521083D0 (en) Compositions for treatment and methods thereof